Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells

Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells

Many metabolic phenotypes in cancer cells are also characteristic of proliferating nontransformed mammalian cells, and attempts to distinguish between phenotypes resulting from oncogenic perturbation from those associated with increased proliferation are limited. Here, we examined the extent to whic...

Full description

Bibliographic Details
Main Authors: Keibler, Mark A. (Author), Dong, Wentao (Author), Korthauer, Keegan D. (Author), Hosios, Aaron M. (Author), Moon, Sun Jin (Author), Sullivan, Lucas B. (Author), Liu, Nian (Author), Abbott, Keene L. (Author), Arevalo, Orlando D. (Author), Ho, Kailing (Author), Lee, Jennifer (Author), Phanse, Aasavari S. (Author), Kelleher, Joanne K. (Author), Iliopoulos, Othon (Author), Coloff, Jonathan L. (Author), Vander Heiden, Matthew G. (Author), Stephanopoulos, Gregory (Author)
Format: Article
Language:English
Published: Wiley, 2022-02-16T17:50:20Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items